Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2010 1
2012 1
2013 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Development of Paroxetine Hydrochloride Single Layer Controlled-Release Tablets Based on 3² Factorial Design.
Yang Y, Huang Z, Zhang X, Li J, Huang Y, Chen W, Pan X, Wu C. Yang Y, et al. Pharmaceutics. 2018 Nov 20;10(4):243. doi: 10.3390/pharmaceutics10040243. Pharmaceutics. 2018. PMID: 30463329 Free PMC article.
However, the complicated double-layer production of PAXIL() CR faces the risk of layer separation. In this study, PHH enteric coating single layer controlled-release tablets (PHH-EC-SLTs) were designed as a simplified substitution of PAXIL() CR through …
However, the complicated double-layer production of PAXIL() CR faces the risk of layer separation. In this study, PHH enteric …
Development and comparative evaluation of in vitro, in vivo properties of novel controlled release compositions of paroxetine hydrochloride hemihydrate as against Geomatrix™ platform technology.
Khatavkar UN, Shimpi SL, Jayaram Kumar K, Deo KD. Khatavkar UN, et al. Drug Dev Ind Pharm. 2013 Aug;39(8):1175-86. doi: 10.3109/03639045.2012.682222. Epub 2012 May 21. Drug Dev Ind Pharm. 2013. PMID: 22607046
The objective of this study is to develop, in vitro and in vivo evaluation of novel approaches for controlled release of paroxetine hydrochloride hemihydrate (PHH) in comparison to patented formulation PAXIL CR() tablets of GlaxoSmithKline (Geomatrix technology). In …
The objective of this study is to develop, in vitro and in vivo evaluation of novel approaches for controlled release of paroxetine hydrochl …